BridgeMD
New treatment option for Dislocation Shoulder
Official title Rehabilitation by Multifactorial Approach After a Latarjet Procedure
ClinicalTrials.gov ID: NCT06154889
What this study is testing
- What it's testing
- Kinesiophobia (fear of physical movement) is common after a previous shoulder dislocation and persists after one year, regardless of the occurrence of a recurrence. This kinesiophobia is associated with a lower level of physical activity and a lower return to sport.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 67
You may be able to join if
- Primary or recurrent traumatic anterior dislocation of the shoulder
- Indication of abutment according to Latarjet (arthroscopic or open sky)
- Age: 18-67 years
- Understanding of the French language spoken and written
- Written informed consent (in accordance with to ICH-GCP guidelines)
You likely can't join if
- Posterior or multidirectional instability of the shoulder (Beighton score \>5)
- Age \ 67 years.
- Patients with additional rotator cuff tear.
- Patients with a history of surgery on either shoulder.
- Patients with connective tissue disorders (eg Ehler-Danlos).
- Patients with (current) anxiety disorders or using anxiolytic medications (eg, antipsychotics) (criterion based on patient record/indications).
See the full eligibility criteria
- Primary or recurrent traumatic anterior dislocation of the shoulder
- Indication of abutment according to Latarjet (arthroscopic or open sky)
- Age: 18-67 years
- Understanding of the French language spoken and written
- Written informed consent (in accordance with to ICH-GCP guidelines)
- Posterior or multidirectional instability of the shoulder (Beighton score \>5)
- Age \ 67 years.
- Patients with additional rotator cuff tear.
- Patients with a history of surgery on either shoulder.
- Patients with connective tissue disorders (eg Ehler-Danlos).
- Patients with (current) anxiety disorders or using anxiolytic medications (eg, antipsychotics) (criterion based on patient record/indications).
- Patients with neurological disorders or systemic disease.
- Patients with inflammatory disease, rheumatoid arthritis or active malignancy.
- Patients previously hospitalized for shoulder pain
- Patients with upper tubercle fracture
- Patients with motor neurological deficit
- Pregnant or breastfeeding patient
- Patient protected under protective measure
The study team makes the final eligibility decision.
Where it's taking place
- Annecy, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 67 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Annecy, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.